K

Kansas Medical Clinic | KMC Research Center

Research site
(Unclaimed)
Location
2200 SW 6th Avenue, Topeka, Kansas, United States of America

Site insights

Top conditions

Top treatments

Relamorelin
IW-3718
Xifaxan
SPD476
NG101
Vonoprazan
Retinoid
Obeticholic Acid
Lebrikizumab
Vancomycin

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 16 total trials

Long-term Safety and Efficacy Study of Lebrikizumab (LY3650150) in Participants With Moderate-to-Severe Atopic Dermatitis (ADjoin)

This is designed to assess the long-term safety and efficacy of lebrikizumab for moderate-to-severe atopic dermatitis. It will last up to 33 months.

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Trial sponsors

Allergan logo
Lilly logo
AbbVie logo
Bausch Health logo
Genentech logo
I
Ironwood Pharmaceuticals logo
J
N
Phathom Pharmaceuticals logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems